肠上皮细胞Ceacam1的缺陷可以预防耐固醇耐药的急性肠道移植与宿主疾病
Qingxiao Song1,2,3,4, Moqian Zheng1,2, Qinjian Li1,2
1Arthur D. Riggs Diabetes and Metabolism Research Institute, The Beckman Research Institute, and.
JCI insight
|September 9, 2025
概括
将CEACAM1向肠上皮细胞可以预防耐固醇性肠急性移植对宿主疾病 (SR-Gut-aGVHD). 这种方法促进有益的肠道细菌和抗炎性免疫细胞,提供了一种新的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 移植 移植 移植 移植
背景情况:
- 固醇耐药性肠道急性移植对宿主疾病 (SR-Gut-aGVHD) 是血造细胞移植后死亡的主要原因.
- 在SR-Gut-aGVHD的关键因素包括增加的IL-22+T细胞,肠道失生症和减少的抗炎单核细胞 (MNP).
- 肠上皮细胞 (IEC) 上的CEACAM1参与调节细菌转位和肠道免疫.
研究的目的:
- 调查CEACAM1在SR-Gut-aGVHD病变发生中的作用.
- 评估针对CEACAM1在IEC中用于SR-Gut-aGVHD预防的治疗潜力.
主要方法:
- 使用成像质细胞计 (IMC),用ATAC-Seq进行单细胞RNA测序 (scRNA-Seq) 和高维流细胞计.
- 用SR-Gut-aGVHD的小鼠模型来评估Ceacam1缺陷对宿主IEC的影响.
- 分析包括免疫细胞概况,细菌社区评估和MNP特征.
主要成果:
- 在小鼠和人类SR-Gut-aGVHD的IEC中,CEACAM1表达升高.
- 在宿主IEC中Ceacam1缺乏,对小鼠的SR-Gut-aGVHD有显著的保护.
- 赛卡姆1缺乏导致有益的共生细菌增加,扩大调节性T细胞 (pTregs),增强抗炎MNP,同时减少促炎细胞.
结论:
- 在IEC上CEACAM1表达是SR-Gut-aGVHD发展的关键因素.
- 向IEC CEACAM1通过调节肠道微生物群和免疫细胞群来改善SR-Gut-aGVHD.
- 在IEC中针对CEACAM1是一个有希望的战略,用于预防SR-Gut-aGVHD.
更多相关视频
07:34Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
Published on: December 16, 2021
3.1K
08:25A Rat Graft Rejection Model of Intestinal Transplantation with Exteriorized Ileostomy for Longitudinal Prognosis Assessment
Published on: June 10, 2025
510
相关概念视频
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
904
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
904
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
439
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
439
01:23Renewal of Intestinal Stem Cells
3.2K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
3.2K
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.4K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.4K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
495
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
495
01:30Inflammatory Bowel Disease II: Crohn's Disease
961
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
961